Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein staining
Feasibility of immunohistochemical staining of P-glycoprotein for the prediction of doxorubicin resistance in gastrointestinal cancers was examined. Among 10 cancer cell lines which consist of two gastric cancer cell lines and eight colon cancer cell lines, seven cell lines were stained positively b...
Gespeichert in:
| Veröffentlicht in: | European journal of cancer (1990) 1992, Vol.28 (8), p.1422-1427 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1427 |
|---|---|
| container_issue | 8 |
| container_start_page | 1422 |
| container_title | European journal of cancer (1990) |
| container_volume | 28 |
| creator | Yamauchi, Masaji Kumazawa, Heiji Satta, Tetsuya Sugawara, Isamu Isobe, Kenichi Kodera, Yasuliro Ito, Katsuki Watanabe, Tadashi Takagi, Hiroshi |
| description | Feasibility of immunohistochemical staining of P-glycoprotein for the prediction of doxorubicin resistance in gastrointestinal cancers was examined. Among 10 cancer cell lines which consist of two gastric cancer cell lines and eight colon cancer cell lines, seven cell lines were stained positively by the monoclonal antibody to P-glycoprotein, C219. In consequence of the evaluation on the effect of doxorubicin on these tumour cells by means of succinic dehydrogenase inhibition test (SDI test), zero out of seven cell lines stained positively by C219 was sensitive to doxorubicin, but two out of three cell lines stained negatively were sensitive. Among 23 fresh surgical specimens of gastrointestinal cancers which consisted of 15 gastric cancers and eight colon cancers, seven tumour tissues were stained positively by C219. All P-glycoprotein positive tumours were resistant to doxorubicin. On the other hand, four of 16 P-glycoprotein negative tumours were sensitive to doxorubicin. These data indicate that positively stained cancer cells by C219 are resistant to doxorubicin. |
| doi_str_mv | 10.1016/0959-8049(92)90536-B |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73157605</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>095980499290536B</els_id><sourcerecordid>73157605</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-e17f4977db314ad9af917d7c4032684e52f8f7574f4a9b280d87acf195c76fba3</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotVb_gcKsRBejyUwymWwEW3xBwS504yZk8iiR6aQmGbH_3owtunN1uZxz7uMD4BTBKwRRdQ0ZYXkNMbtgxSWDpKzy6R4Yo5qyHNak2AfjX8shOArhHUJIawxHYIRKQkrMxuBt4bWyMlrXZc5kyn053zdW2i7zOtgQRSd1lrqlCNE720Udou1Em8lB8VmzyRb5st1It_Yu6uRMGdvZbnkMDoxogz7Z1Ql4vb97mT3m8-eHp9ntPJeYFDHXiBrMKFVNibBQTBiGqKISw7KoaqxJYWpDCcUGC9YUNVQ1FdIgRiStTCPKCTjfzk0HfPTpPL6yQeq2FZ12feC0RIRWic8E4K1ReheC14avvV0Jv-EI8gEpH3jxgRdnBf9Byqcpdrab3zcrrf5CW4ZJv9nqOj35abXnQVqd4CjrtYxcOfv_gm8xd4dx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73157605</pqid></control><display><type>article</type><title>Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein staining</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yamauchi, Masaji ; Kumazawa, Heiji ; Satta, Tetsuya ; Sugawara, Isamu ; Isobe, Kenichi ; Kodera, Yasuliro ; Ito, Katsuki ; Watanabe, Tadashi ; Takagi, Hiroshi</creator><creatorcontrib>Yamauchi, Masaji ; Kumazawa, Heiji ; Satta, Tetsuya ; Sugawara, Isamu ; Isobe, Kenichi ; Kodera, Yasuliro ; Ito, Katsuki ; Watanabe, Tadashi ; Takagi, Hiroshi</creatorcontrib><description>Feasibility of immunohistochemical staining of P-glycoprotein for the prediction of doxorubicin resistance in gastrointestinal cancers was examined. Among 10 cancer cell lines which consist of two gastric cancer cell lines and eight colon cancer cell lines, seven cell lines were stained positively by the monoclonal antibody to P-glycoprotein, C219. In consequence of the evaluation on the effect of doxorubicin on these tumour cells by means of succinic dehydrogenase inhibition test (SDI test), zero out of seven cell lines stained positively by C219 was sensitive to doxorubicin, but two out of three cell lines stained negatively were sensitive. Among 23 fresh surgical specimens of gastrointestinal cancers which consisted of 15 gastric cancers and eight colon cancers, seven tumour tissues were stained positively by C219. All P-glycoprotein positive tumours were resistant to doxorubicin. On the other hand, four of 16 P-glycoprotein negative tumours were sensitive to doxorubicin. These data indicate that positively stained cancer cells by C219 are resistant to doxorubicin.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/0959-8049(92)90536-B</identifier><identifier>PMID: 1355349</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 ; Cell Line ; Colonic Neoplasms - pathology ; Doxorubicin - therapeutic use ; Drug Resistance ; Evaluation Studies as Topic ; Gastrointestinal Neoplasms - chemistry ; Gastrointestinal Neoplasms - drug therapy ; Humans ; Immunohistochemistry ; Membrane Glycoproteins - analysis ; Stomach Neoplasms - pathology</subject><ispartof>European journal of cancer (1990), 1992, Vol.28 (8), p.1422-1427</ispartof><rights>1992</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-e17f4977db314ad9af917d7c4032684e52f8f7574f4a9b280d87acf195c76fba3</citedby><cites>FETCH-LOGICAL-c452t-e17f4977db314ad9af917d7c4032684e52f8f7574f4a9b280d87acf195c76fba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/095980499290536B$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1355349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamauchi, Masaji</creatorcontrib><creatorcontrib>Kumazawa, Heiji</creatorcontrib><creatorcontrib>Satta, Tetsuya</creatorcontrib><creatorcontrib>Sugawara, Isamu</creatorcontrib><creatorcontrib>Isobe, Kenichi</creatorcontrib><creatorcontrib>Kodera, Yasuliro</creatorcontrib><creatorcontrib>Ito, Katsuki</creatorcontrib><creatorcontrib>Watanabe, Tadashi</creatorcontrib><creatorcontrib>Takagi, Hiroshi</creatorcontrib><title>Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein staining</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>Feasibility of immunohistochemical staining of P-glycoprotein for the prediction of doxorubicin resistance in gastrointestinal cancers was examined. Among 10 cancer cell lines which consist of two gastric cancer cell lines and eight colon cancer cell lines, seven cell lines were stained positively by the monoclonal antibody to P-glycoprotein, C219. In consequence of the evaluation on the effect of doxorubicin on these tumour cells by means of succinic dehydrogenase inhibition test (SDI test), zero out of seven cell lines stained positively by C219 was sensitive to doxorubicin, but two out of three cell lines stained negatively were sensitive. Among 23 fresh surgical specimens of gastrointestinal cancers which consisted of 15 gastric cancers and eight colon cancers, seven tumour tissues were stained positively by C219. All P-glycoprotein positive tumours were resistant to doxorubicin. On the other hand, four of 16 P-glycoprotein negative tumours were sensitive to doxorubicin. These data indicate that positively stained cancer cells by C219 are resistant to doxorubicin.</description><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1</subject><subject>Cell Line</subject><subject>Colonic Neoplasms - pathology</subject><subject>Doxorubicin - therapeutic use</subject><subject>Drug Resistance</subject><subject>Evaluation Studies as Topic</subject><subject>Gastrointestinal Neoplasms - chemistry</subject><subject>Gastrointestinal Neoplasms - drug therapy</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Membrane Glycoproteins - analysis</subject><subject>Stomach Neoplasms - pathology</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEUhYMotVb_gcKsRBejyUwymWwEW3xBwS504yZk8iiR6aQmGbH_3owtunN1uZxz7uMD4BTBKwRRdQ0ZYXkNMbtgxSWDpKzy6R4Yo5qyHNak2AfjX8shOArhHUJIawxHYIRKQkrMxuBt4bWyMlrXZc5kyn053zdW2i7zOtgQRSd1lrqlCNE720Udou1Em8lB8VmzyRb5st1It_Yu6uRMGdvZbnkMDoxogz7Z1Ql4vb97mT3m8-eHp9ntPJeYFDHXiBrMKFVNibBQTBiGqKISw7KoaqxJYWpDCcUGC9YUNVQ1FdIgRiStTCPKCTjfzk0HfPTpPL6yQeq2FZ12feC0RIRWic8E4K1ReheC14avvV0Jv-EI8gEpH3jxgRdnBf9Byqcpdrab3zcrrf5CW4ZJv9nqOj35abXnQVqd4CjrtYxcOfv_gm8xd4dx</recordid><startdate>1992</startdate><enddate>1992</enddate><creator>Yamauchi, Masaji</creator><creator>Kumazawa, Heiji</creator><creator>Satta, Tetsuya</creator><creator>Sugawara, Isamu</creator><creator>Isobe, Kenichi</creator><creator>Kodera, Yasuliro</creator><creator>Ito, Katsuki</creator><creator>Watanabe, Tadashi</creator><creator>Takagi, Hiroshi</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1992</creationdate><title>Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein staining</title><author>Yamauchi, Masaji ; Kumazawa, Heiji ; Satta, Tetsuya ; Sugawara, Isamu ; Isobe, Kenichi ; Kodera, Yasuliro ; Ito, Katsuki ; Watanabe, Tadashi ; Takagi, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-e17f4977db314ad9af917d7c4032684e52f8f7574f4a9b280d87acf195c76fba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1</topic><topic>Cell Line</topic><topic>Colonic Neoplasms - pathology</topic><topic>Doxorubicin - therapeutic use</topic><topic>Drug Resistance</topic><topic>Evaluation Studies as Topic</topic><topic>Gastrointestinal Neoplasms - chemistry</topic><topic>Gastrointestinal Neoplasms - drug therapy</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Membrane Glycoproteins - analysis</topic><topic>Stomach Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamauchi, Masaji</creatorcontrib><creatorcontrib>Kumazawa, Heiji</creatorcontrib><creatorcontrib>Satta, Tetsuya</creatorcontrib><creatorcontrib>Sugawara, Isamu</creatorcontrib><creatorcontrib>Isobe, Kenichi</creatorcontrib><creatorcontrib>Kodera, Yasuliro</creatorcontrib><creatorcontrib>Ito, Katsuki</creatorcontrib><creatorcontrib>Watanabe, Tadashi</creatorcontrib><creatorcontrib>Takagi, Hiroshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamauchi, Masaji</au><au>Kumazawa, Heiji</au><au>Satta, Tetsuya</au><au>Sugawara, Isamu</au><au>Isobe, Kenichi</au><au>Kodera, Yasuliro</au><au>Ito, Katsuki</au><au>Watanabe, Tadashi</au><au>Takagi, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein staining</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>1992</date><risdate>1992</risdate><volume>28</volume><issue>8</issue><spage>1422</spage><epage>1427</epage><pages>1422-1427</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>Feasibility of immunohistochemical staining of P-glycoprotein for the prediction of doxorubicin resistance in gastrointestinal cancers was examined. Among 10 cancer cell lines which consist of two gastric cancer cell lines and eight colon cancer cell lines, seven cell lines were stained positively by the monoclonal antibody to P-glycoprotein, C219. In consequence of the evaluation on the effect of doxorubicin on these tumour cells by means of succinic dehydrogenase inhibition test (SDI test), zero out of seven cell lines stained positively by C219 was sensitive to doxorubicin, but two out of three cell lines stained negatively were sensitive. Among 23 fresh surgical specimens of gastrointestinal cancers which consisted of 15 gastric cancers and eight colon cancers, seven tumour tissues were stained positively by C219. All P-glycoprotein positive tumours were resistant to doxorubicin. On the other hand, four of 16 P-glycoprotein negative tumours were sensitive to doxorubicin. These data indicate that positively stained cancer cells by C219 are resistant to doxorubicin.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>1355349</pmid><doi>10.1016/0959-8049(92)90536-B</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-8049 |
| ispartof | European journal of cancer (1990), 1992, Vol.28 (8), p.1422-1427 |
| issn | 0959-8049 1879-0852 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73157605 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | ATP Binding Cassette Transporter, Subfamily B, Member 1 Cell Line Colonic Neoplasms - pathology Doxorubicin - therapeutic use Drug Resistance Evaluation Studies as Topic Gastrointestinal Neoplasms - chemistry Gastrointestinal Neoplasms - drug therapy Humans Immunohistochemistry Membrane Glycoproteins - analysis Stomach Neoplasms - pathology |
| title | Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein staining |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T03%3A04%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prediction%20of%20doxorubicin%20resistance%20in%20gastrointestinal%20cancer%20by%20P-glycoprotein%20staining&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Yamauchi,%20Masaji&rft.date=1992&rft.volume=28&rft.issue=8&rft.spage=1422&rft.epage=1427&rft.pages=1422-1427&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/0959-8049(92)90536-B&rft_dat=%3Cproquest_cross%3E73157605%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73157605&rft_id=info:pmid/1355349&rft_els_id=095980499290536B&rfr_iscdi=true |